Cangene
Cangene receives continued funding to develop therapy for acute radiation syndrome
Published in Genetics and Environmental Business Week, March 16th, 2006
PEG-GM-CSF is a chemically modified version of the company's Leucotropin, a proprietary version of the white-blood-cell stimulating protein, granulocyte-macrophage colony-stimulating factor (GM-CSF). GM-CSF is a protein that stimulates the production of certain infection-fighting white blood cells, which can be depleted by radiation exposure thereby leaving patients susceptible to harmful infections.
An earlier CRTI-funded...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics and Environmental Business Week
More Articles from Genetics and Environmental Business Week
- Cardica, Inc.
Cardica files post-effective amendment - Critical Therapeutics, Inc.
Biopharma company reports initial data from launch of ZYFLO (zileuton tablets) - Genomic Health, Inc.
Genomic Health announces Q4 revenue of $1.9 million - Kleiner Perkins Caufield & Byers
Venture capital group Kleiner forms $600 million IT life sciences, medical devices fund - Kleiner Perkins Caufield & Byers
Venture services company Kleiner Perkins forms $200 million pandemic and biodefense fund - ZymoGenetics, Inc.
Milestone payments boost ZymoGenetics' Q4 2005 results, year losses down from 2004 - More from this issue of Genetics and Environmental Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
